Stokes Capital Advisors LLC grew its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 32.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,307 shares of the company’s stock after purchasing an additional 18,154 shares during the quarter. Colgate-Palmolive comprises approximately 1.9% of Stokes Capital Advisors LLC’s portfolio, making the stock its 25th largest holding. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $5,725,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of the business. Geode Capital Management LLC raised its position in shares of Colgate-Palmolive by 0.6% during the 1st quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock valued at $1,309,583,000 after buying an additional 112,177 shares during the period. Moneta Group Investment Advisors LLC raised its position in shares of Colgate-Palmolive by 90,253.2% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after buying an additional 15,956,771 shares during the period. Morgan Stanley raised its position in shares of Colgate-Palmolive by 41.7% during the 4th quarter. Morgan Stanley now owns 11,370,549 shares of the company’s stock valued at $895,886,000 after buying an additional 3,345,297 shares during the period. Northern Trust Corp raised its position in shares of Colgate-Palmolive by 0.5% during the 1st quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock valued at $793,971,000 after buying an additional 50,040 shares during the period. Finally, Deutsche Bank AG raised its position in shares of Colgate-Palmolive by 6.2% during the 1st quarter. Deutsche Bank AG now owns 8,485,041 shares of the company’s stock valued at $637,651,000 after buying an additional 493,252 shares during the period. 78.36% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, insider Jennifer Daniels sold 24,704 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.31, for a total transaction of $1,811,050.24. Following the completion of the transaction, the insider now owns 52,813 shares in the company, valued at $3,871,721.03. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, insider Jennifer Daniels sold 24,704 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.31, for a total value of $1,811,050.24. Following the completion of the sale, the insider now directly owns 52,813 shares of the company’s stock, valued at $3,871,721.03. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 48,627 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.37, for a total transaction of $3,567,762.99. Following the completion of the sale, the chief executive officer now directly owns 246,969 shares of the company’s stock, valued at $18,120,115.53. The disclosure for this sale can be found here. Over the last quarter, insiders sold 105,501 shares of company stock worth $7,838,332. Corporate insiders own 0.34% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on CL
Colgate-Palmolive Stock Up 0.2 %
Shares of NYSE:CL traded up $0.18 during trading on Monday, hitting $73.35. The company’s stock had a trading volume of 775,720 shares, compared to its average volume of 4,668,885. The business has a 50 day moving average price of $75.06 and a two-hundred day moving average price of $75.85. The company has a market capitalization of $60.64 billion, a PE ratio of 40.65, a P/E/G ratio of 3.10 and a beta of 0.50. The company has a debt-to-equity ratio of 28.43, a quick ratio of 0.73 and a current ratio of 1.17. Colgate-Palmolive has a fifty-two week low of $67.84 and a fifty-two week high of $82.09.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings results on Friday, July 28th. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.75 by $0.02. The business had revenue of $4.82 billion during the quarter, compared to the consensus estimate of $4.70 billion. Colgate-Palmolive had a net margin of 8.02% and a return on equity of 386.76%. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.72 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.17 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be paid a dividend of $0.48 per share. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.62%. Colgate-Palmolive’s payout ratio is currently 106.67%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Bank Stocks – Best Bank Stocks to Invest In
- 5 Reasons Mullen Automotive is About to Turn a Corner
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Qualcomm and Apple Forge Ahead with New Modem Partnership
- Energy and Oil Stocks Explained
- Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.